Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles



Status:Archived
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:Any
Updated:7/1/2011

Use our guide to learn which trials are right for you!

Investigations of Megakaryocytes From Patients With Abnormal Platelet Vesicles


Congenital bleeding disorders characterized by abnormal platelet granules include Gray
Platelet syndrome (GPS; defective alpha-granules), Hermansky-Pudlak syndrome (HPS; defective
delta-granules), and combined alpha delta-storage pool deficiency (alpha delta-SPD). Other
diseases associated with variable defects in platelet gamma-granules include
Chediak-Higashi, Griscelli, Wiskott-Aldrich, and Thrombocytopenia Absent Radius syndromes.
These disorders are models for the study of organelle formation in megakaryocytes and
platelets. Characteristics of megakaryocytopoiesis in these disorders have not been
investigated because megakaryocytes could not be cultured from patients in sufficient
quantities for experimental purposes. Recent advances have made it possible to culture
megakaryocytes using serum-free media supplemented with recombinant human thrombopoietin
(TPO). Such cultured human megakaryocytes, amplified from bone marrow-derived CD34+ stem
cells, synthesize and store organellar proteins and produce functional platelets. In this
protocol, we plan to obtain bone marrow aspirates from 40 children and adults (ages 2 to 80
years) with GPS, HPS, and related disorders. Patients admitted to the NIH Clinical Center on
specific disease-related protocols will be enrolled in this protocol during their routine
3-5 day visits. We will culture megakaryocytes from CD34+ stem cells isolated from bone
marrow aspirates. Studies of cultured megakaryocytes will include evaluation of granule
membrane and soluble proteins using fluorescent antibodies and immunoelectron microscopy and
comparison of RNA and protein expression patterns between normal and patient cells.
Precautions will be taken to prevent the primary risk of the bone marrow aspiration, i.e.,
prolonged bleeding at the aspiration site. Standard diagnostic studies on the bone marrow
sample may reveal information that may directly benefit patients. However, the broader
benefit of this study is the acquisition of a better understanding of the characteristics of
functional platelet disorders and the process of intracellular vesicle formation.


Congenital bleeding disorders characterized by abnormal platelet granules include Gray
Platelet syndrome (GPS; defective alpha-granules), Hermansky-Pudlak syndrome (HPS; defective
delta-granules), and combined alpha delta-storage pool deficiency (alpha delta-SPD). Other
diseases associated with variable defects in platelet gamma-granules include
Chediak-Higashi, Griscelli, Wiskott-Aldrich, and Thrombocytopenia Absent Radius syndromes.
These disorders are models for the study of organelle formation in megakaryocytes and
platelets. Characteristics of megakaryocytopoiesis in these disorders have not been
investigated because megakaryocytes could not be cultured from patients in sufficient
quantities for experimental purposes. Recent advances have made it possible to culture
megakaryocytes using serum-free media supplemented with recombinant human thrombopoietin
(TPO). Such cultured human megakaryocytes, amplified from bone marrow-derived CD34+ stem
cells, synthesize and store organellar proteins and produce functional platelets. In this
protocol, we plan to obtain bone marrow aspirates from 40 children and adults (ages 2 to 80
years) with GPS, HPS, and related disorders. Patients admitted to the NIH Clinical Center on
specific disease-related protocols will be enrolled in this protocol during their routine
3-5 day visits. We will culture megakaryocytes from CD34+ stem cells isolated from bone
marrow aspirates. Studies of cultured megakaryocytes will include evaluation of granule
membrane and soluble proteins using fluorescent antibodies and immunoelectron microscopy and
comparison of RNA and protein expression patterns between normal and patient cells.
Precautions will be taken to prevent the primary risk of the bone marrow aspiration, i.e.,
prolonged bleeding at the aspiration site. Standard diagnostic studies on the bone marrow
sample may reveal information that may directly benefit patients. However, the broader
benefit of this study is the acquisition of a better understanding of the characteristics of
functional platelet disorders and the process of intracellular vesicle formation.


We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
301-496-2563
National Institutes of Health Clinical Center The National Institutes of Health (NIH) Clinical Center in...
?
mi
from
Bethesda, MD
Click here to add this to my saved trials